This inventor holds 1 USPTO granted patent. Top assignee: Hanwha Chemical Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovator Profile: Il Sun Lee
Introduction
Il Sun Lee, an accomplished inventor based in Daejeon, South Korea, has made significant contributions in the field of medical therapeutics. With a focus on developing innovative solutions for inflammatory diseases and cancer, his work has the potential to improve patient outcomes and provide new avenues for treatment.
Latest Patents
Il Sun Lee holds a patent for a human monoclonal antibody that specifically binds to VCAM-1, along with a therapeutic composition for treating inflammatory diseases or cancer. This groundbreaking invention relates to a monoclonal antibody that exhibits a strong affinity to VCAM-1 on endothelial cells. It effectively inhibits leukocyte adhesion to activated endothelial cells, showing promise in the treatment of various conditions including asthma, rhinitis, arthritis, multiple sclerosis, bowel disease, arteriosclerosis, myocardial infarction, and transplant rejection. Notably, this invention also demonstrates low immunogenicity, which is a valuable characteristic for therapeutic applications.
Career Highlights
Il Sun Lee is currently employed at Hanwha Chemical Corporation, where he continues to push the boundaries of scientific research and innovation. His role at the company underscores his commitment to developing effective therapeutics that address pressing health issues.
Collaborations
In his pursuit of innovation, Il Sun Lee collaborates with talented individuals such as Jung Tae Lee and Kyung Duk Moon. These professional partnerships play a crucial role in fostering a dynamic research environment that enhances the potential for impactful discoveries.
Conclusion
Il Sun Lee exemplifies the spirit of innovation within the field of biomedical research. His patent for a human monoclonal antibody not only highlights his inventive capabilities but also provides hope for effective treatments for challenging health conditions. Through his work at Hanwha Chemical Corporation and collaborations with other skilled professionals, Il Sun Lee is poised to make lasting contributions to the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile